Department of Philosophy and Classics

Permanent URI for this collectionhttp://197.255.125.131:4000/handle/123456789/23076

Browse

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations
    (Vaccine, 2022) Singh, J.A.; Kochhar, S.; Wolff, J.; Atuire, C.; Bhan, A.; Emanuel, E.; Faden, R.; Ghimire, P.; Greco, D.; Ho, C.; Moon, S.; Shamsi-Gooshki, E.; Touré, A.; Thomé, B.; Smith, M.J.; Upshur, R.E.G.
    While the degree of COVID-19 vaccine accessibility and uptake varies at both national and global levels, increasing vaccination coverage raises questions regarding the standard of prevention that ought to apply to different settings where COVID-19 vaccine trials are hosted. A WHO Expert Group has developed guidance on the ethical implications of conducting placebo-controlled trials in the context of expanding global COVID-19 vaccine coverage. The guidance also considers alternative trial designs to placebo controlled trials in the context of prototype vaccines, modified vaccines, and next generation vaccines